Moreover, BTZ single treatment stimulated compensatory protein internalization, which can refuel amino acids by autophagic degradation (Figure 5D–J).[23] Through bypassing these mechanisms, the dual‐drug combination strategy exhausted intracellular amino acids and prompted an exacerbated anti‐cancer effect. Here, CASC3 is linked to cancer.